Literature DB >> 1538125

Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene.

S C Gautam1, N F Chikkala, T A Hamilton.   

Abstract

We examined the effects of IL-4, a cytokine produced by Th2 cells, on the development of an Ag-specific, T cell-mediated inflammatory response in a hapten-induced model of contact sensitivity (CS). Intravenous administration of IL-4 was ineffective in modulating the development of CS when administered on days 0, 1, and 2 after sensitization with the hapten trinitrochlorobenzene. In contrast, such treatment significantly reduced the response when given on the day of challenge. Conversely, treatment with anti-IL-4 mAb on day 4 markedly increased the magnitude of CS but was without effect when administered on days 0, 1, and 2. These results suggest that IL-4 interferes with CS at the efferent but not the afferent limb of the response. IL-4 had no inhibitory effect on the ability of immune lymph node cells to transfer adoptively CS or their proliferation upon restimulation with hapten. However, the expression of CS by immune cells was severely curtailed in mice treated with IL-4 prior to immune cell transfer. Furthermore, IL-4 inhibited monokine (gamma-IFN inducible protein [IP-10] and TNF-alpha) expression in macrophages induced by treatment with culture supernatants from the Ag-stimulated immune lymph node cells. These results indicate that suppression of Ag-specific inflammatory CS response by IL-4 may be mediated at least in part through inhibition of cytokine production by mononuclear phagocytes infiltrating the site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538125

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Inflammatory and immune mechanisms in contact hypersensitivity (CHS) in rats.

Authors:  A Popov; I Mirkov; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  The role of interleukin-4 in ultraviolet B light-induced immunosuppression.

Authors:  A A el-Ghorr; M Norval
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

3.  Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.

Authors:  C M Hogaboam; B A Vallance; A Kumar; C L Addison; F L Graham; J Gauldie; S M Collins
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice.

Authors:  F Dieli; G Sireci; E Scirè; A Salerno; A Bellavia
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

5.  Interleukin-4 is a critical cytokine in contact sensitivity.

Authors:  A Salerno; F Dieli; G Sireci; A Bellavia; G L Asherson
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

6.  Lymphokine profiles in contact sensitivity induced by dinitrofluorobenzene and tolerance induced by dinitrothiocyanobenzene.

Authors:  L Wei; K M Müller; J H Saurat; C Hauser
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

7.  Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.

Authors:  J E Domer; L G Human; G B Andersen; J A Rudbach; G L Asherson
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses.

Authors:  J A Thomson; A B Troutt; A Kelso
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

9.  IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B Streptococcus infection.

Authors:  Luciana Tissi; Francesco Bistoni; Manuela Puliti
Journal:  Mediators Inflamm       Date:  2009-07-07       Impact factor: 4.711

10.  Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot.

Authors:  Luigi Uccioli; Anna Sinistro; Cristiana Almerighi; Chiara Ciaprini; Antonella Cavazza; Laura Giurato; Valeria Ruotolo; Francesca Spasaro; Erika Vainieri; Giovanni Rocchi; Alberto Bergamini
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.